Capital Performance Advisors LLP Bristol Myers Squibb CO Transaction History
Capital Performance Advisors LLP
- $310 Million
- Q4 2024
A detailed history of Capital Performance Advisors LLP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Capital Performance Advisors LLP holds 6,186 shares of BMY stock, worth $340,106. This represents 0.11% of its overall portfolio holdings.
Number of Shares
6,186
Previous 4,961
24.69%
Holding current value
$340,106
Previous $256,000
36.33%
% of portfolio
0.11%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,749Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.4 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.72 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.28 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.23 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.32 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $117B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...